NIMG-67. ADVANCED PERFUSION AND DIFFUSION MR IMAGING IN GLIOBLASTOMA PATIENTS TREATED WITH TUMOR TREATING FIELDS (TTFIELDS) AS FIRST-LINE THERAPY

BACKGROUND: Tumor treating fields (TTFields) is an antimitotic and FDA-approved first and second-line therapy for patients with glioblastoma. In recurrent glioblastoma, it has been reported that imaging response to TTFields is generally delayed (~158 days), where 44% of responders developed initial...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Connelly, Jennifer M, Prah, Melissa A, Schmainda, Kathleen M
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692961/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.640
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki